Episode # 200 • 19 Nov 2024
Managing Biochemical Recurrence After Prostate Radiation
Biochemical recurrence of prostate cancer can be difficult to diagnose and treat. In this episode of BackTable Urology, where Dr. Aditya Bagrodia hosts Dr. Amar Kishan, a genitourinary radiation oncologist at UCLA, to discuss the complexities of biochemical recurrence and local failure after radiation therapy for prostate cancer.
This podcast is supported by
Timestamps
00:00 - Introduction
04:31 - PSA Levels Post-Radiation
13:21 - Local Recurrence and PSMA PET
21:29 - Explaining Radiation Effects to Patients
22:41 - Managing PSA Bounce
26:05 - Imaging and Biopsy Techniques
28:55 - Treatment Options for Local Recurrence
30:16 - Re-Irradiation and Focal Therapy
33:13 - Concluding Thoughts
Resources
You may also like
More about this episode
First, they evaluate alternatives to androgen deprivation therapy (ADT), the benefits and risks associated with ADT, and the role of genetic classifier tests. They also detail the goals of prostate-specific antigen (PSA) monitoring, PSA trends post-radiation, and advancements in PSMA PET scans. Then, the conversation highlights modern treatment options like targeted radiation, low dose rate brachytherapy, salvage radical prostatectomy, and focal therapy. Finally, the doctors emphasize personalized and multidisciplinary treatment plans as they hope to improve long-term outcomes for patients with prostate cancer.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.